Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugh M Jones

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|May 14, 2005
Do selective serotonin reuptake inhibitors cause suicide? Discrediting old drugs may be useful in marketing new onesHugh M Jones
The American Journal of Psychiatry|February 3, 2004
On biology, phenomenology, and pharmacology in schizophreniaHugh M Jones
BMJ (Clinical Research Ed.)|March 1, 2003
Low dosage tricyclic antidepressants in depression. Giving low dose tricyclics is not justified by evidenceHugh M Jones
The American Journal of Psychiatry|April 6, 2006
Hallucinations during lamotrigine treatment of bipolar disorderRudolf Uher, Hugh M Jones
Expert Review of Neurotherapeutics|October 9, 2009
New targets for antipsychoticsHugh M Jones, Lyn S Pilowsky
Journal of Psychopharmacology (Oxford, England)|April 27, 2004
Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinityRodrigo A Bressan, Hugh M Jones, Lyn S Pilowsky
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|June 10, 2009
Working memory span and motor and cognitive speed in schizophreniaGildas Brébion, Anthony S David, Hugh M Jones, et al.
Journal of the International Neuropsychological Society : JINS|August 19, 2007
Visual memory errors in schizophrenic patients with auditory and visual hallucinationsGildas Brébion, Anthony S David, Ruth Ohlsen, et al.
Neuropsychologia|September 26, 2006
Temporal context discrimination in patients with schizophrenia: associations with auditory hallucinations and negative symptomsGildas Brébion, Anthony S David, Hugh M Jones, et al.
Schizophrenia Research|June 27, 2002
Typical antipsychotic drugs -- D(2) receptor occupancy and depressive symptoms in schizophreniaRodrigo A Bressan, Durval C Costa, Hugh M Jones, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|May 14, 2005
Do selective serotonin reuptake inhibitors cause suicide? Discrediting old drugs may be useful in marketing new onesHugh M Jones
The American Journal of Psychiatry|February 3, 2004
On biology, phenomenology, and pharmacology in schizophreniaHugh M Jones
BMJ (Clinical Research Ed.)|March 1, 2003
Low dosage tricyclic antidepressants in depression. Giving low dose tricyclics is not justified by evidenceHugh M Jones
The American Journal of Psychiatry|April 6, 2006
Hallucinations during lamotrigine treatment of bipolar disorderRudolf Uher, Hugh M Jones
Expert Review of Neurotherapeutics|October 9, 2009
New targets for antipsychoticsHugh M Jones, Lyn S Pilowsky
Journal of Psychopharmacology (Oxford, England)|April 27, 2004
Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinityRodrigo A Bressan, Hugh M Jones, Lyn S Pilowsky
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|June 10, 2009
Working memory span and motor and cognitive speed in schizophreniaGildas Brébion, Anthony S David, Hugh M Jones, et al.
Journal of the International Neuropsychological Society : JINS|August 19, 2007
Visual memory errors in schizophrenic patients with auditory and visual hallucinationsGildas Brébion, Anthony S David, Ruth Ohlsen, et al.
Neuropsychologia|September 26, 2006
Temporal context discrimination in patients with schizophrenia: associations with auditory hallucinations and negative symptomsGildas Brébion, Anthony S David, Hugh M Jones, et al.
Schizophrenia Research|June 27, 2002
Typical antipsychotic drugs -- D(2) receptor occupancy and depressive symptoms in schizophreniaRodrigo A Bressan, Durval C Costa, Hugh M Jones, et al.
Pageof 2